- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GlaxoSmithkline Pharmaceuticals Ltd (GLAX)
GlaxoSmithkline Pharmaceuticals Ltd stock price live, this page displays NSE GLAX stock exchange data. View the GLAX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GlaxoSmithkline Pharmaceuticals Ltd real time stock price chart below.
What Is the GlaxoSmithkline Pharmaceuticals Ltd Stock Price Today?
The GlaxoSmithkline Pharmaceuticals Ltd stock price today is 2,655.40.
What Is the Stock Symbol for GlaxoSmithkline Pharmaceuticals Ltd?
The stock symbol for GlaxoSmithkline Pharmaceuticals Ltd is "GLAX."
What Stock Exchange Does GlaxoSmithkline Pharmaceuticals Ltd Trade On?
GlaxoSmithkline Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is GlaxoSmithkline Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether GlaxoSmithkline Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLAX quote. (ISIN: INE159A01016)
What Is the GlaxoSmithkline Pharmaceuticals Ltd Stock Price Today?
The GlaxoSmithkline Pharmaceuticals Ltd stock price today is 2,655.40.
What Is the Stock Symbol for GlaxoSmithkline Pharmaceuticals Ltd?
The stock symbol for GlaxoSmithkline Pharmaceuticals Ltd is "GLAX."
What Stock Exchange Does GlaxoSmithkline Pharmaceuticals Ltd Trade On?
GlaxoSmithkline Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is GlaxoSmithkline Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether GlaxoSmithkline Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLAX quote. (ISIN: INE159A01016)
2,655.40
+44.70(+1.71%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,564.70
2,679.00
52 wk Range
2,088.10
3,184.30
GLAX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,564.702,679.00
52 wk Range
2,088.103,184.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GLAX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
May 13, 2026
EPS / Forecast
16.40 / --
Revenue / Forecast
9.95B / 10.72B
Compare GLAX to Peers and Sector
Metrics to compare | GLAX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLAXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 43.4x | 33.5x | −0.3x | |
PEG Ratio | 3.71 | 1.73 | 0.00 | |
Price/Book | 19.8x | 7.2x | 2.6x | |
Price / LTM Sales | 11.8x | 7.5x | 3.0x | |
Upside (Analyst Target) | 8.8% | 2.9% | 56.7% | |
Fair Value Upside | Unlock | 2.6% | 9.4% | Unlock |
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease; and Seretide. In addition, the company offers general medicines, including Augmentin, an oral antibiotic for respiratory tract infections, surgical prophylaxis, dental infections, and skin infections; Ceftum, an anti-infective medicine; Calpol and Calpol T for pain management; Eltroxin for the treatment of hypothyroidism; Neosporin, Betnovate, T-bact, Physiogel, Tenovate, and Flutivate for dermatology indications; and CobadexCZS and CCM, which are mineral, vitamins, and nutrition products. Further, it provides oncology medicines, including Jemperli and Zejula. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. The company was incorporated in 1924 and is headquartered in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GlaxoSmithkline Pharma (GLAX) Stock Price Today?
The GlaxoSmithkline Pharma stock price today is 2,655.40 INR.
What Stock Exchange Does GlaxoSmithkline Pharma Trade On?
GlaxoSmithkline Pharma is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for GlaxoSmithkline Pharma?
The stock symbol for GlaxoSmithkline Pharma is "GLAX."
Does GlaxoSmithkline Pharma Pay Dividends? What’s The Current Dividend Yield?
The GlaxoSmithkline Pharma dividend yield is 2.18%.
What Is the GlaxoSmithkline Pharma Market Cap?
As of today, GlaxoSmithkline Pharma market cap is 449.51B INR.
What Is GlaxoSmithkline Pharma's Earnings Per Share (TTM)?
The GlaxoSmithkline Pharma EPS (TTM) is 61.15.
When Is the Next GlaxoSmithkline Pharma Earnings Date?
GlaxoSmithkline Pharma will release its next earnings report on Aug 03, 2026.
From a Technical Analysis Perspective, Is GLAX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has GlaxoSmithkline Pharma Stock Split?
GlaxoSmithkline Pharma has split 1 times.
How Many Employees Does GlaxoSmithkline Pharma Have?
GlaxoSmithkline Pharma has 3103 employees.
What is the current trading status of GlaxoSmithkline Pharma (GLAX)?
As of Aug 01, 2026, GlaxoSmithkline Pharma (GLAX) is trading at a price of 2,655.40 INR, with a previous close of 2,610.70 INR. The stock has fluctuated within a day range of 2,564.70 INR to 2,679.00 INR, while its 52-week range spans from 2,088.10 INR to 3,184.30 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.